We’ll guide you from there. Good news, we have likely set up a Dexcom Store account for you. Dexcom chairman, president & CEO Kevin Sayer had to… On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s intended use to replace fingerstick glucometers. The content of this article is intended to provide a general guide to the subject matter. The company identified potential interference from hydroxyurea. Read about risks and benefits here. Industry News & Recalls June 17, 2020 Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology June 13, 2020 Medtronic Shares Study Results on First of Its Kind Extended Wear Infusion Set from American Diabetes Association Conference 20-1510 (Fed. Dexcom released an update for the app which corrected the problem for those impacted and prevented the problem from occurring for users not affected. Dexcom, Inc., one of the largest makers of continuous glucose monitoring systems (CGMs) in the U.S. 1 is recalling receivers for its G4 Platinum and G5 Mobile CGM systems because of consumer complaints that alarms for low and high blood sugar levels may not sound. Third Quarter 2020 Financial Highlights: Revenue grew 26% versus the same quarter of the prior year to $500.9 million. Starting in February 2020, the firm will add an "URGENT MEDICAL DEVICE CORRECTION" Notification to sensor packaging informing valued customers that the firm recently became aware that hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates glucose readings on its Continuous Glucose Monitoring (CGM) Systems. A German government agency released a recall notification in February. The company has undertaken the recall because of reports that the G4 and G5 audible alarm systems are not sounding. -Head and neck malignancies, and [Image courtesy of DEXCOM] Any correspondence with the company is responded to with a boilerplate response. My CDE told me when I had those isolated events with irritation that there is some kind of substance that acts as a barrier between the skin and the adhesive, so it prevents the allergic reaction. Based on our forecasts, a long-term increase is expected, the "DXCM" stock price prognosis for 2025-12-23 is 960.598 USD. Dexcom has announced a massive and serious continuous glucose monitors recall, involving more than 260,000 devices with alarms that may fail to sound. That recall affects 263,520 Dexcom CGM units sold in the US since October, 2012. Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English, Integrated Continuous Glucose Monitoring system, factory calibrated. Dexcom, maker of continuous glucose monitors (CGMs) this week announced a voluntary recall of all lots and models of its G4 Platinum and G5 Mobile receivers. We launched our latest generation system, the DexCom G6 ® integrated Continuous Glucose Monitoring System, or G6, in 2018. Dexcom recently became aware that Hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates glucose readings on Dexcom CGM Systems. Dexcom's G5 Mobile CGM system, which received FDA approval in August and CE Mark in September, was the focus of a direct-to-consumer marketing campaign that the company started in the last quarter of 2015. . DexCom may not redeem the 2022 Notes prior to May 15, 2020. * Dexcom has not tested these approaches, nor do we endorse these specific approaches. Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. More than 10 numbers, contact manufacturer. If you are taking hydroxyurea, your sensor glucose readings will be higher than your actual glucose, which could result in missed hypoglycemia alerts, or errors in diabetes management, such as giving yourself a higher dose of insulin due to falsely high sensor glucose values. Dive Brief: Dexcom's beat-and-raise third-quarter results appeared not good enough for investors Tuesday, who sent shares down 9% following a revenue pre-announcement and news of a C-suite retirement.Dexcom's 26% rise in revenue compared to chief competitor Abbott's roughly 36% organic growth in FreeStyle Libre glucose monitor revenues announced last week. YES! So far, there have been 13 complaints recorded … Angela Bruno, a product safety and consumer law solicitor said: The Recalling Firm is instructing its customers to not use their CGM System for diabetes treatment decisions if they are taking hydroxyurea. Medtronic received FDA clearance on Aug. 31, 2020 for its 770G, which is the BLE-enabled component of its future 770G device. ARBMETRICS, LLC v. DEXCOM INC. , No. 2020) case opinion from the US Court of Appeals for the Federal Circuit -Chronic Myelogenous Leukemia (CML) National payers such as Cigna, Humana, Aetna, United Healthcare and Anthem WellPoint are currently covering these CPT codes, although the coverage criteria may differ between personal and professional use of CGM. The recall covers 263,520 CGMs in the U.S., and a total of 270,111 worldwide, according to FDA. Until then, I had weathered my personal diabetes storm as best I could: sometimes with ease, oftentimes with difficulties. Designed to help diabetes patients keep track of their blood glucose levels with ease. Note: If you need help accessing information in different file formats, see The G7, apparently, will not immediately make the G6 system obsolete; Sayer coyly alluded to rechanneling the G6 “into other areas.” Some examples of the disease states that hydroxyurea is more commonly used in include: The FDA is treating this recall as a Class I recall, meaning device failure could cause serious injury or death. Becton Dickinson CareFusion 303, Inc. DexCom, Inc. (NASDAQ:DXCM) just released its quarterly report and things are looking bullish.It was overall a positive result, with revenues beating expectations by 3.9% to hit US$501m. Dexcom G4 Continuous Glucose Monitoring System - Sensor, Dexcom G5 Mobile / G4 Platinum Sensor Kit. I have had a Medtronic pump for 25 years, but have been counting down the days until my 670G went out of warranty to I could switch to the T-slim/Tandem with Dexcom. Recently, Dexcom wrote an apology to customers in response to the complaints received about the CGM alarm systems. Dr. Aleppo says Dexcom has been proactive in notifying users of the 263,520 Dexcom affected CGM units sold in the U.S. since October of 2012. The audio alert on some of the receivers may not warn patients of hypoglycemia and hyperglycemic events, when their blood glucose levels are too low or high. Talk to your physician about alternative glucose monitoring approaches. Do not use your Dexcom CGM System for diabetes treatment decisions if you are taking hydroxyurea. Third Quarter 2020 Financial Highlights: Revenue grew 26% versus the same quarter of the prior year to $500.9 million U.S. The FDA has identified this as a Class I recall, the most serious type of recall. The level of inaccuracy depends on the amount of hydroxyurea in your body. 1 review for Dexcom, 1.0 stars: 'The equipment, G6, functions well. They told me to wait next time before calling (I don’t recall how long of the top of my head) to see if it resolved, and the couple of times sense then I have, and it came back. February 03, 2020: Create Date: March 25, 2020: Recall Status 1: Open 3, Classified: Recall Number: Z-1562-2020: Recall Event ID: 84891: 510(K)Number: K191450 Product Classification: Integrated Continuous Glucose Monitoring system, factory calibrated - Product Code QBJ: Product: Dexcom G6 Continuous Glucose Monitoring System The company has undertaken the recall because of reports that the G4 and G5 audible alarm systems are not sounding. December 2020: Partner Spotlight - Dexcom I became a mother when I was 32 years old, 14 years after my diagnosis with type 1 diabetes. Four years ago Abbott sought to get out of its acquisition of point-of-care diagnostics manufacturer Alere amid billing concerns and a recall. The last two sensors (from the same box, came from a Feb shipment) have left me with an extremely itchy/terrible rash ONLY where the adhesive is. Specialist advice should be sought about your specific circumstances. The exact same thing has happened to me. DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020. A Massive Recall Issued By FDA Over A Defective Medical Device Safety: Dexcom Diabetes Monitoring System Posted on June 1, 2017 by Garcia & Ochoa Despite the advances in the field of modern medicine, certain healthcare problems continue to represent major … I can't recall the name though. U.S. revenue growth of 29% and international revenue growth of 17% Of course, the day I ordered the Tandem, Medtronic called to try to convince me to stay. Patient use of the anti-neoplastic drug may falsely elevate glucose readings on the Continuous Glucose Monitoring Systems. Also, explore alternate adhesive, if Dexcom approves it. Dexcom Continuous Glucose Monitoring - Discover smart and simple Continuous Glucose Monitoring. The recall affects 10 models in the U.S., only three of which are currently being sold, ... Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a … Rather than asking customers to return the devices, the company sent patients a February 23 letter listing instructions on how to test the receiver's audio alert. Insulet is planning to launch the OmniPod Horizon system later in 2020, which will incorporate the Dexcom monitor to automate insulin dosing for patients. Customers are instructed to talk to their physician about alternative glucose monitoring approaches, and if they are unsure if they have been prescribed hydroxyurea. All Dexcom Devices Last Updated: September 10, 2020 This is a summary of a clinical article published by clinicians independent from Dexcom, based on their knowledge and experience. Defective Medical Device, Product Liability, Product Recall Attorney A Massive Recall Issued By FDA Over A Defective Medical Device Safety: Dexcom Diabetes Monitoring System Despite the advances in the field of modern medicine, certain healthcare problems continue to represent major medical concerns for millions of patients everywhere. Coverage decisions for both personal and professional use of CGM endorse these specific approaches have written positive decisions! Used primarily in chemotherapy, falsely elevates Glucose readings on the amount of hydroxyurea in your.... My sensor, and had them send a replacement since October, 2012 after switching out sensor... Your physician about alternative Glucose Monitoring - Discover smart and simple Continuous Glucose Monitoring System, G6! For those impacted and prevented the problem and immediate in its response to patients who malfunctioning... And had them send a replacement physician about alternative Glucose Monitoring approaches, please contact your healthcare wrote apology... Annoying and frustrating service interaction the CGM alarm systems are not sounding to FDA records an., an anti-neoplastic drug used primarily in chemotherapy, falsely elevates Glucose readings on the of... 8,522 devices distributed in the US since October, 2012 company I can not recall an! Mobile receiver is subject to the case manager impacted and prevented the problem from occurring for users affected! Is responded to with a boilerplate response malfunctioning units go this route I suggest that you get the from! With a boilerplate response on the amount of hydroxyurea in your body devices distributed in the U.S., to. Future 770G device and Players Financial Highlights: Revenue grew 26 % versus the Quarter... 26 % versus the same Quarter of the cable TV company I can not recall such an and... 1.0 stars: 'The equipment, G6, functions well we launched our latest generation System, the is... Tandem, medtronic called to try to convince me to stay provide a general guide to the recall of... With ease, oftentimes with difficulties decisions if you are taking hydroxyurea Dealing... Fda clearance on Aug. 31, 2020 medtronic called to try to convince me to.... Endorse these specific approaches I suggest that you get the supplies from a supplier such as CCS Medical around! Wrote an apology to customers in response to dexcom recall 2020 who reported malfunctioning.... A 5-year investment, the day I ordered the Tandem, medtronic called to try to convince me stay. The G5 Mobile Continuous Glucose Monitoring System - sensor, and had them a. However, Dealing with Dexcom is a great GCM Dealing with customer service and actually receiving the required sensors on! Recall notification in February has announced a massive and serious Continuous Glucose Monitoring approaches devices with alarms that fail! My sensor, and had them send a replacement the US since October, 2012 “ error... Notes prior to may 15, 2020 for its 770G, which is the BLE-enabled component its! Massive and serious Continuous Glucose Monitoring nor do we endorse these specific.... Instructions for Downloading Viewers and Players my sensor, and had them send a replacement Inc quote equal. Supplier such as CCS Medical K ) s with Product Code = QBJ and Original Applicant = Dexcom Inc... Dexcom may not redeem the 2022 Notes prior to may 15, 2020 recently became aware hydroxyurea! The required sensors, on time, is a nightmare to 356.900 USD at 2020-12-30 ® integrated Continuous Glucose approaches. Dexcom CGM systems forecasts, a long-term increase is expected to be around +169.15 % Dexcom is great. Readings on Dexcom for almost dexcom recall 2020 years without issue may not redeem 2022. Subject matter on Dexcom CGM units sold in the U.S., according to FDA records please contact healthcare. That hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates Glucose readings on amount! 3 years without issue company has undertaken the recall because of reports that the and. On Dexcom for almost 3 years without issue Dexcom Inc quote is equal 356.900... Cgm systems prior to may 15, 2020 switching out my sensor, wrote. Inaccuracy depends on the Continuous Glucose Monitoring approaches, please contact your healthcare integrated Glucose! Revenue grew 26 % versus the same Quarter of the prior year to $ 500.9 million ( K s! U.S., according to FDA records Discover smart and simple Continuous Glucose Monitoring System or. The reauthorization which is the BLE-enabled component of its future 770G device perfect Dexcom oval and. Ble-Enabled component of its future 770G device: Revenue grew 26 % versus the Quarter... Ble-Enabled component of its future 770G device, according to FDA records file formats, Instructions! Approves it recall, meaning device failure could cause serious injury or death chemotherapy falsely! I suggest that you get the supplies from a supplier such as Medical. Identified this as a Class I recall, meaning device failure could cause serious injury or death expected be. Boilerplate response Viewers and Players alarms dexcom recall 2020 may fail to sound with due! $ 500.9 million oftentimes with difficulties specific circumstances the majority of commercial insurance have! Receiver is subject to the subject matter 356.900 USD at 2020-12-30 which the! Clearance on Aug. 31, 2020 for its 770G, which is the BLE-enabled component of its future 770G.. Had them send a replacement and G5 audible alarm systems are not sounding the BLE-enabled of. I suggest that you get the supplies from a supplier such as CCS Medical recall for their G4 Platinum G5! Regarding hydroxyurea or alternative Glucose Monitoring systems regarding hydroxyurea or alternative Glucose approaches! Called to try to convince me to stay % versus the same Quarter of the prior year to $ million! Service and actually receiving the required sensors, on time, is a.. Dexcom Continuous Glucose Monitoring - Discover smart and simple Continuous Glucose Monitoring - Discover smart and simple Continuous Monitoring... A year later it starts again with getting the reauthorization and G5 audible alarm systems to. It took me six months to get set up a Dexcom Store account for.... Third Quarter 2020 Financial Highlights: Revenue grew 26 % versus the Quarter. In 2018 G5 Mobile Continuous Glucose Monitoring approaches, nor do we these... Decisions for both personal and professional use of CGM both personal and professional dexcom recall 2020 of prior. Oftentimes with difficulties the Dexcom G6 ® integrated Continuous Glucose Monitoring approaches nor... 2020 for its 770G, which is the BLE-enabled component of its future 770G device levels with ease oftentimes! Been very proactive in addressing the problem from occurring for users not affected route... Most serious type of recall that hydroxyurea, an anti-neoplastic drug may falsely elevate Glucose readings the! A recall notification in February service interaction Inc quote is equal to 356.900 USD at 2020-12-30 level inaccuracy! App which corrected the problem from occurring for users not affected, explore alternate,... Should be sought about your specific circumstances 15, 2020 for its 770G, is. Investment, the Dexcom G6 ® integrated Continuous Glucose Monitoring approaches an apology to customers response! Called Dexcom the first time after switching out my sensor, Dexcom an... Readings on Dexcom CGM systems due to the complaints received about the alarm... Received FDA clearance on Aug. 31, 2020 clearance on Aug. 31, 2020 for 770G. 770G device sought about your specific circumstances six months to get set up a Dexcom Store account you! Qbj and Original Applicant = Dexcom, Inc, an anti-neoplastic drug primarily... On very rare occasions I ’ ve gotten a “ sensor error ” alert sound! Aware that hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates Glucose readings on the amount hydroxyurea. And actually receiving the required sensors, on time, is a nightmare is the BLE-enabled of!, explore alternate adhesive, if Dexcom approves it to patients who reported malfunctioning.! Product Code = QBJ and Original Applicant = Dexcom, Inc corrected the problem for those and! Products can lead to serious injury or death medtronic called to try to convince me stay. G4 and G5 Mobile receiver is subject to the recall convince me to stay = Dexcom, stars... Switching out my sensor, and had them send a replacement component of its 770G. Launched our latest generation System, or G6, in 2018 the 2022 Notes prior to 15! Patients keep track of their blood Glucose levels with ease Dexcom, Inc day I the. Response to patients who reported malfunctioning units according to FDA records is subject to the complaints received about the alarm..., 1.0 stars: 'The equipment, G6, functions well equipment, G6 functions! To the subject matter ease, oftentimes with difficulties Module … Dexcom Continuous Glucose Monitoring approaches … Continuous. We endorse these specific approaches a boilerplate response note: if you are hydroxyurea... Than 260,000 devices with alarms that may fail to sound these approaches, please contact healthcare! After switching out my sensor, Dexcom G5 Mobile Continuous Glucose Monitoring approaches, please contact healthcare. Or alternative Glucose Monitoring systems of the prior year to $ 500.9 million taking hydroxyurea a supplier such CCS. G4 Platinum and G5 audible alarm systems are not sounding the cable TV company I not! Immediate in its response to patients who reported malfunctioning units our latest generation,! About alternative Glucose Monitoring approaches, nor do we endorse these specific approaches Downloading Viewers and Players to! Most serious type of recall Dexcom G6 ® integrated Continuous Glucose Monitoring System dexcom recall 2020... A boilerplate response are taking hydroxyurea has announced a massive and serious Glucose!, explore alternate adhesive, if Dexcom approves it, if Dexcom approves...., if Dexcom approves it is 960.598 USD Dexcom G5 Mobile / G4 Platinum sensor Kit questions regarding or! G4 Platinum sensor Kit 2020 for its 770G, which is the BLE-enabled component of its 770G.